AEF0117 not checked

Aelis Farma · 3ß- pregn-5-en-20-one

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
5 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“2 mg AEF0117 containing approximately 100 μCi of \[4-14C\]AEF0117”In the company’s words, NCT05554926 on ClinicalTrials.gov
Tested for
Marijuana Abuse (4 trials), Cannabis Abuse
Main trialPhase 2
“Cannabis use is increasing and will only further escalate with legalization of recreational and medical cannabis use in western countries , with a prevalence greater than 30 % in the US and most European countries for individuals between 16 and 24 years of age. Approximately 9 % of those who use cannabis will become addicted. The number goes up to about 1 in 6 among those who start using cannabis as teenagers and to 25 to 50 % among those who smoke cannabis daily. The consequences of cannabis abuse in the most prone population (14-25 years of age) are extremely serious, and may include…”In the company’s words, NCT03717272 on ClinicalTrials.gov
Other names
3ß- pregn-5-en-20-one

Other drugs for Marijuana Abuse

All 4 drugs for Marijuana Abuse

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 2Completed 31 Jul 2020 Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
Phase 2Completed 11 Apr 2024 Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
Phase 1Completed 24 Feb 2023 Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
Phase 1Terminated 26 Jun 2023 The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers
Phase 1Withdrawn Jun 2026 Drug-Drug Interaction Between THC and AEF0117
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow AEF0117

Following is part of Solo: you see every change to AEF0117 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in